Semi-Annual Statement Of Income

Immuno-Biological Laboratories Co., Ltd. - Filing #7370747

Concept	2023-04-01 to 2023-09-30	2023-04-01 to 2023-09-30	2023-04-01 to 2023-09-30	2023-04-01 to 2023-09-30	2023-04-01 to 2023-09-30	2022-04-01 to 2022-09-30	2022-04-01 to 2022-09-30	2022-04-01 to 2022-09-30	2022-04-01 to 2022-09-30	2022-04-01 to 2022-09-30
Semi-annual statement of income
Statement of income
Net sales	2,106,000 JPY	363,410,000 JPY	365,516,000 JPY	JPY	365,516,000 JPY	JPY	1,986,000 JPY	291,179,000 JPY	293,166,000 JPY	293,166,000 JPY
Cost of sales	—	—	150,245,000 JPY	—	—	—	—	—	119,966,000 JPY	—
Ordinary profit (loss)	—	—	30,639,000 JPY	—	—	—	—	—	-129,668,000 JPY	—
Gross profit (loss)	—	—	215,270,000 JPY	—	—	—	—	—	173,199,000 JPY	—
Selling, general and administrative expenses	—	—	200,643,000 JPY	—	—	—	—	—	227,761,000 JPY	—
Extraordinary losses	—	—	769,000 JPY	—	—	—	—	—	1,913,000 JPY	—
Selling, general and administrative expenses
Profit (loss) before income taxes	—	—	29,869,000 JPY	—	—	—	—	—	-131,581,000 JPY	—
Operating profit (loss)	-3,079,000 JPY	17,706,000 JPY	14,627,000 JPY	JPY	14,627,000 JPY	JPY	-8,024,000 JPY	-46,537,000 JPY	-54,561,000 JPY	-54,561,000 JPY
Income taxes - current	—	—	3,007,000 JPY	—	—	—	—	—	4,586,000 JPY	—
Non-operating income	—	—	16,588,000 JPY	—	—	—	—	—	16,315,000 JPY	—
Non-operating income
Interest income	—	—	47,000 JPY	—	—	—	—	—	630,000 JPY	—
Non-operating expenses	—	—	576,000 JPY	—	—	—	—	—	91,421,000 JPY	—
Income taxes	—	—	3,007,000 JPY	—	—	—	—	—	4,586,000 JPY	—
Non-operating expenses
Interest expenses	—	—	533,000 JPY	—	—	—	—	—	536,000 JPY	—
Profit (loss)	—	—	26,861,000 JPY	—	—	—	—	—	-136,168,000 JPY	—
Extraordinary losses
Impairment losses	—	—	602,000 JPY	—	—	—	—	—	804,000 JPY	—